Role of xanthine oxidase and its inhibitor in hypoxia: Reoxygenation injury

Pediatrics

Volumn 98, Issue 1, 1996, Pages 103-107

  Saugstad, Ola Didrik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

allopurinol; hypoxanthine; hypoxia reoxygenation injury; xanthine dehydrogenase oxidase

Indexed keywords

ALLOPURINOL; OXIDOREDUCTASE INHIBITOR; OXYGEN RADICAL; XANTHINE OXIDASE;

CELL DAMAGE; CELL HYPOXIA; ENZYME CHEMISTRY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; MICHAELIS MENTEN KINETICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; REVIEW;

ANIMALS; ANOXIA; ENZYME INHIBITORS; HUMANS; OXYGEN; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

EID: 0030002692     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Latham F. The oxygen paradox. Experiments on the effects of oxygen in human anoxia. Lancet. 1951;1:77-81
2. Akiyama K. Studies on myocardial metabolism in the ischemic heart. II. Studies by electron spin resonance. Jpn Circ J. 1969;33:165-170
3. Crowell JW, Jones CE, Smith EE. Effect of allopurinol on hemorrhagic shock. Am J Physiol. 1969;216:744-748
4. Vasko KA, Dewall RA, Riley AM. Effect of allopurinol in renal ischemia. Surgery. 1972;71:787-790
5. Saugstad OD, Aasen AO. Plasma hypoxanthine levels as a prognostic aid of tissue hypoxia. Eur Surg Res. 1980;12:123-129
6. McCord JM, Fridovich I. The reduction of cytochrome C by milk xanthine oxidase. J Biol Chem. 1968;243:5753-5760
7. Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol. 1963;204:317-322
8. Gerlach E, Deuticke B, Dreisbach RH. Zum Verhalten von Nucleotiden und ihren dephosphorylierten Abbauprodukten in der Niere bei Ischämie und kurzzeitiger postischämischer Wiederdurchbluting. Pflugers Arch. 1963;278:296-315
9. Saugstad OD. Hypoxanthine as a measurement of hypoxia. Pediatr Res. 1975;9:158-161
10. Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res. 1988;23: 143-150
11. Laing I, Brown JK, Harkness RA. Clinical and biochemical assessments of damage due to perinatal asphyxia: a double blind trial of a quantitative method. J Clin Pathol. 1988;41:247-252
12. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology. 1981;81:22-29
13. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:354-364
14. Rashid MA, William-Olsson G. Influence of allopurinol on cardiac complications in open heart operations. Ann Thorac Surg. 1991;51: 127-130
15. Tabayashi K, Suzuki Y, Nagamine S, Ito Y, Sekino Y, Mohri H. A clinical trial of allopurinol (Zyloric) for myocardial protection. J Thorac Cardiovasc Surg. 1991;101:713-718
16. Johnson WD, Kayser KL, Brenowitz JB, Saedi SF. A randomized controlled trial of allopurinol in coronary bypass. Am Heart J. 1991;121: 20-24
17. Russell GAB, Cooke RWI. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child. 1995;73:F27-F31
18. Simmonds HA, Reiter S, Nishino T. Hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:1781-1797
19. 2-dependent form (type O). Arch Biochem Biophys. 1976;172:365-379
20. Carpani G, Racchi M, Ghezzi P, Terao M, Garattini E. Purification and characterisation of mouse liver xanthine oxidase. Arch Biochem Biophys. 1990;279:237-241
21. Rajagopolan KV, Handler P. Purification and properties of chicken liver xanthine dehydrogenase. J Biol Chem. 1967;242:4097-4107
22. 2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem. 1990;265: 14170-14175
23. Della Corte E, Stirpe F. The regulation of xanthine oxidase in rat liver: modification of the enzyme activity of rat liver supernatant on storage at 20°C. Biochem J. 1968;108:349-351
24. Della Corte E, Stirpe F. The regulation of rat liver xanthine oxidase. Involvement of the thiol groups in conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem J. 1972;126:739-745
25. 2-dependent types of rat liver xanthine dehydrogenase. J Biol Chem. 1989;264:10015-1022
26. Nishino T, Nishino T, Schopfer LM, Massey V. The reactivity of chicken liver xanthine dehydrogenase with molecular oxygen. J Biol Chem. 1989; 264:2518-2527
27. Cazzaniga G, Terao M, Schiavo PL, et al. Chromosomal mapping, isolation and characterization of the mouse xanthine dehydrogenase gene. Genomics. 1994;23:390-402
28. Minoshima S, Wang Y, Ichida K, Nishino T, Shimizu N. Mapping of the gene for human xanthine dehydrogenase (oxidase) (XDH) to band p23 of chromosome 2. Cytogenet Cell Genet. 1995;68:52-53
29. Ichida K, Amaya Y, Noda K, et al. Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene. Gene. 1993;133:279-284
30. Harkness RA, McCreanor GM, Simpson D, MacFayden IR. Pregnancy in and incidence of xanthine oxidase deficiency. J Inherit Metab Dis. 1986;9:407-408
31. Hunt J, Massey V. Purification and properties of milk xanthine dehydrogenase. J Biol Chem. 1992;267:21479-21485
32. Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem. 1994;116:1-6
33. Nishino T, Tamura I. The mechanism of conversion of xanthine dehydrogenase to oxidase and the role of the enzyme in reperfusion injury. Adv Exp Med Biol. 1991;309A:327-337
34. Canada AT, Werkman RF, Mansbach CM, II, Rosen GM. Biochemical changes in the intestine associated with anoxia and reoxygenation: in vivo and in vitro studies. J Free Radic Biol Med. 1986;2:327-334
35. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DA. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med. 1993;15:407-414
36. Ghezzi P, Bianchi M, Mantovani A, Spreafico F, Salmona M. Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun. 1984;119:144-149
37. Ghezzi P, Bianchi M, Gianera L, Landolfo S, Salmona M. Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcystein in mice. Cancer Res. 1985;45:3444-3447
38. Falciani F, Ghezzi P, Terrao M, Cazzaniga G, Garattini E. Interferons induce xanthine dehydrogenase in L929 Cells. Biochem J. 1992;285: 1001-1008
39. Vettenranta K, Raivio KO. Xanthine oxidase during human fetal development. Pediatr Res. 1990;27:286-288
40. al-Khalidi UAS, Chaglassian TH. The species distribution of xanthine oxidase. Biochemistry. 1965;97:318-320
41. Watts RWE, Watts JEM, Seegmiller JE. Xanthine oxidase activity in human tissues and its inhibition by allopurinol(4-hydroxypyrazolo [3,4-D] pyrimidine). J Lab Clin Med. 1965;66:688-697
42. Parks DA, Granger DN. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand. 1986;548(suppl):87-99
43. Saugstad OD, Schrader H. The determination of inosine and hypoxanthine in the rat brain during normothermic and hypothermic anoxia. Acta Neurol Scand. 1978;57:281-288
44. Betz AL. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J Neurochem. 1985;44:574-579
45. Betz AL, Randall J, Martz D. Xanthine oxidase is not a major source of free radicals in focal cerebral ischemia. Am J Physiol. 1991;260:H563-H568
46. Terada LS, Willingham IR, Rosandich ME, Leff JA, Kindt GW, Repine JE. Generation of superoxide anion by brain endothelial cell xanthine oxidase. J Cell Physiol. 1991;148:191-196
47. Lindsay S, Liu T-H, Xu J, et al. Role of xanthine dehydrogenase and oxidase in focal cerebral ischemic injury to rat. Am J Physiol. 1991;261: H2051-H2057
48. Cardelli P, Fiori A, Santulli MC, et al. Effect of inorganic phosphate on hypoxanthine transport in isolated brain microvessels. Biochem Int. 1992; 28:823-834
49. Wajner M, Harkness RA. Distribution of xanthine dehydrogenase and oxidase activities in human and rabbit tissues. Biochim Biophys Acta. 1989;991:79-84
50. Bruder G, Jaratsch E-D, Heid HW. High concentrations of antibodies to xanthine oxidase in human and animal sera. J Clin Invest. 1984;74: 783-794
51. Kökoglu E, Belce A, Özyurt E, Tepeler Z. Xanthine oxidase levels in human brain tumors. Cancer Lett. 1990;50:179-181
52. Saksela M, Raivio KO. Expression of xanthine oxidase (XO) in relation to perinatal organ damage. Pediatr Res. 1995;37:235A. Abstract
53. Grum CM, Ragsdale RA, Ketai LH, Shlafer M. Absence of xanthine oxidase or xanthine dehydrogenase in the rabbit myocardium. Biochem Biophys Res Commun. 1986;141:1104-1108
54. Muxfeldt M, Schaper W. The activity of xanthine oxidase in heart of pigs, guinea pigs, rabbits, and humans. Basic Res Cardiol. 1987;82: 486-492
55. Downey JM, Hearse DJ, Yellon DM. The role of xanthine oxidase during myocardial ischemia in several species including man. J Mol Cell Cardiol. 1988;20(suppl II):55-63
56. de Jong JW, van der Meer P, Nieukoop AS, Huizer T, Stroeve RJ, Bos E. Xanthine oxidoreductase activity in perfused hearts of various species, including humans. Circ Res. 1990;67:770-773
57. Zweier JL, Broderick R, Kuppusamy P, Thompson-Gorman S, Lutty GA. Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem. 1994;269:24156-24162
58. Saugstad OD, Gluck L. Plasma hypoxanthine levels in newborn infants: a specific indicator of hypoxia. J Perinat Med. 1982;10:266-272
59. Saugstad OD, Hallman M, Abraham JL, Epstein B, Cochrane C, Gluck L. Hypoxanthine and oxygen induced lung injury: a possible basic mechanism of tissue damage? Pediatr Res. 1984;18:501-504
60. Saugstad OD. Oxygen radicals and pulmonary damage. Pediatr Pulmonol. 1985;1:167-175
61. Tan S, Radi R, Gaudier F, et al. Physiologic levels of uric acid inhibit xanthine oxidase in plasma. Pediatr Res. 1993;34:303-307
62. Yokoyama Y, Beckman JS, Beckman TK, et al. Circulating xanthine oxidase: potential mediators of ischemic injury. Am J Physiol. 1990;258: G564-G570
63. Grum CM, Ragsdale RA, Ketai LH, Simon RH. Plasma xanthine oxidase in patients with adult respiratory distress syndrome. J Crit Care. 1987; 2:22-26
64. Friedl HP, Smith DJ, Till GO, Thompson PD, Louise DS, Ward PA. Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. Am J Pathol. 1990;136:491-495
65. Supnet MC, David-Cu R, Walther FJ. Plasma xanthine oxidase and lipid hydroperoxide levels in preterm infants. Pediatr Res. 1994;36:283-287
66. Rootwelt T, Almaas R, Øyasæter S, Moen A, Saugstad OD. Release of xanthine oxidase to the systemic circulation during resuscitation from severe hypoxemia in newborn pigs. Acta Paediatr. 1995;84:507-511
67. Adachi T, Fukushima T, Usami Y, Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial cell-surface. Biochem J. 1993;289:523-527
68. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol. 1992;32: 297-311
69. Elion GB, Kovensky A, Hitchings GH, Metz E, Rundless RW. Metabolic studies of allopurinol, an inhibitor of xanthine oxidase. Biochem Pharmacol. 1966;15:863-880
70. McGaurn SP, Davis LE, Krawczeniuk M, et al. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome. Pediatrics. 1994;94:820-823
71. Vaughan W, Horton J, Walker P. Allopurinol prevents intestinal permeability changes after ischemia-reperfusion injury. J Pediatr Surg. 1992; 27:968-972
72. Toledo-Pereya L-H, Simmons RL, Rajarian JS. Effect of allopurinol on the preservation of ischemic kidneys perfused with plasma or plasma substitutes. Ann Surg. 1974;5:780-782
73. Werns SW, Shea MJ, Mitsos SE, et al. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. Circulation. 1986; 73:518-524
74. Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res. 1990;27:332-336
75. 31P NMR study in unanesthetized immature rats. Neurosci Lett. 1992;144: 103-106
76. +-ATPase activity during hypoxia in newborn piglets. Brain Res. 1994;650:9-15
77. Boda D, Nemeth I, Hencz P, Denes K. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev Pharmacol Ther. 1984;7:357-367
78. Moorhouse PC, Grootveld M, Halliwell B, Quinlan JG, Gutteridge JMC. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett. 1987;213:23-28
79. Das DK, Engelman RM, Clement R, Otani H, Prasad MR, Rao PS. Role of xanthine oxidase inhibitor as a free radical scavenger: a novel mechanism in myocardial salavage. Biochem Biophys Res Commun. 1987;148: 314-319
80. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Neuroprotective role of adenosine in cerebral ischemia. Trends Pharmacol Sci. 1992;13: 439-445
81. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA. 1981;78: 6858-6862
82. Sanderud J, Norstein J, Saugstad OD. Reactive oxygen metabolites produce pulmonary vasoconstriction in young pigs. Pediatr Res. 1991; 29:543-547
83. Clyman RI, Saugstad OD, Mauray F. Reactive oxygen metabolites relax the lamb ductus arteriosus by stimulating prostaglandin production. Circ Res. 1989;64:1-8